BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
BioPharm Executive - Money Talk
Silicon Valley’s Hottest Tech Accelerator, Y Combinator, To Debut Biotech Startups 8/19/2014
Bay Area's HealthQuest Capital Bags $110 Million For Debut Fund With Healthcare, Medtech Focus 8/19/2014
San Diego's Otonomy, Inc. (OTIC) Prices Upsized IPO High End Of Range, $16 A Share 8/13/2014
Multiple Sclerosis Biotech Forward Pharma Files For $200 Million IPO 8/12/2014
Already-Rich Juno Therapeutics Reels In Another $134 Million, Has Raised $300 Million In Less Than 12 Months 8/6/2014
New Cambridge-Based Biotech VC Firm Remiges BioPharma Emerges, Eyes $150 Million Fund 7/25/2014
Sofinnova Ventures Raises $500 Million Biotech Venture Fund 7/23/2014
StemCells Inc. (STEM) Announces Closing Of $20 Million Offering 7/21/2014
VC Firm Versant Ventures Closes In On $300 Million Fund For Medtech And Biotech 7/9/2014
National Institutes of Health (NIH) Has A New $248 Million Focus: Electroceuticals 7/7/2014
Cambridge Startup Navitor Pharmaceuticals Debuts With $23.5 Million Series A In Pocket 6/20/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/20/2014
Fremont Biotech Ardelyx Inc. (ARDX) Prices IPO At $14 Per Share 6/19/2014
South San Francisco's True North Therapeutics Reels In $22 Million Series A Financing 6/18/2014
Berkeley's Aduro Biotech Reels In $55 Million Series C Financing 6/13/2014
Gene Therapy Biotech Vascular Biogenics Ltd. Files For A $75 Million IPO 6/9/2014
San Francisco Biotech Startup Nurix Taps $25.1 Million Financing 5/27/2014
Fremont-Based Ardelyx Inc. Files For $69 Million IPO 5/22/2014
Gene Therapy Biotech Lysogene Reels In $22 Million 5/21/2014
Santa Monica's Kite Pharma, Inc. Gears Up For IPO Debut 5/21/2014
Kymab Locks Down $40 Million For Antibody Research 5/16/2014
Kite Pharma, Inc. Reels In $50 Million Private Financing 4/28/2014
Cancer-Fighter Juno Therapeutics Completes $176 Million Series A Round 4/24/2014
Aerpio Closes $22 Million Financing 4/23/2014
Massachusett's Zafgen Lines Up $86 Million IPO To Bankroll Obesity Drug Push 4/21/2014
San Diego's Vital Therapies, Inc. (VTI) (VTL) Prices $54 Million IPO 4/17/2014
Redwood City Biopharma, Versartis, Inc. (VSAR), Hits High End With $126 Million IPO 3/21/2014
Cambridge's Akebia Therapeutics, Inc. (AKBA) Hauls In $100 Million In Upsized IPO Debut 3/20/2014
Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995 3/14/2014
San Diego Biopharma Lumena Pharmaceuticals Secures $45 Million In Series B Financing Round 3/11/2014
Billionaire-Backed San Diego Startup, Human Longevity Inc., Gets $70 Million To Take On Aging 3/7/2014
NovImmune SA Finishes $66 Million Series B Financing Round 2/18/2014
Flexion Therapeutics (FLXN) Pulls Off $60 Million In IPO Debut 2/12/2014
NephroGenex (NRX) Prices IPO At Low End Of Range, Will Reap About $37.2 Million 2/11/2014
Argos Therapeutics, Inc. (ARGS) Prices Lower Than Expected IPO, Raises $45 Million 2/7/2014
Eleven Biotherapeutics (EBIO) Prices Downsized IPO, Grabs $50 Million 2/6/2014
Already-Rich Startup, Juno Therapeutics, Expands Series A Funding Round To $145 Million 1/15/2014
Alkermes plc (ALKS) Hauls In $250 Million It Doesn't Need, But It May Prevent It From Being Swallowed Up 1/13/2014
Sanofi (France) (SAN.PA) Pays $700 Million For 12 Percent Of Alnylam Pharmaceuticals (ALNY) 1/13/2014
GlycoMimetics, Inc. (GLYC) Finally Prices Upraised IPO At $8 Per Share 1/10/2014
Amgen (AMGN)'s Bay Area Spinoff, Atara Biotherapeutics, Hauls In $52 Million Series B Financing 1/10/2014
Biotech Startup, Juno Therapeutics, Grabs $120 Million To Coax Immune System To Fight Cancer 12/5/2013
Early Stage Biotech VC, 5AM Ventures, Grabs $250 Million 12/5/2013
Zafgen Racks Up $45 Million Series E Round 12/4/2013
NYCEDC's $100 Million Biotech Fund Aims To Form 15 To 20 New Startups By 2020 12/4/2013
Orexigen Therapeutics, Inc. (OREX) Offers $100 Million Of Convertible Senior Notes 12/3/2013
San Diego’s Vital Therapies, Inc. (VTI) Postpones IPO As Biotech Sector Cools Off 11/22/2013
Flagship VentureLabs Takes A Stab At Microbiome Therapy By Launching New Biotech Seres Health 11/21/2013
Evogene Ltd. (EVGN) Hauls In $74 Million In IPO 11/21/2013
Pfizer Inc. (PFE) Sees Something Special In MissionTherapeutics Ltd, Backs Co With $32 Million Series B 11/18/2013
Karyopharm Therapeutics (KPTI) Raises $109 Million in Upsized IPO, Begins Trading Today 11/6/2013
Pronutria Emerges From Stealth With $10.8 Million, Nutrients to Treat Disease 10/22/2013
Cancer Biotech TetraLogic Pharmaceuticals Files for a $104 Million IPO 10/21/2013
Pain Treatment Biotech Egalet Files for a $69 Million IPO 10/17/2013
Startup Seragon Pharmaceuticals Lands $30 Million in Series A Financing 10/16/2013
Vital Therapies, Inc. (VTI) Files For $86.25 Million IPO 10/14/2013
BIND Therapeutics Scrounges Up $70.5 Million in IPO 9/20/2013
With Support From Celgene (CELG) and Other Investors, Acceleron Pharma Raises $93 Million in IPO 9/19/2013
Five Prime Therapeutics, Inc. (FPRX) Stock Soars After $62 Million IPO 9/18/2013
Civitas Therapeutics Raises $38 Million 9/11/2013
Cubist Pharmaceuticals, Inc. (CBST) Prices $700 Million of Convertible Senior Notes 9/5/2013
MicuRx Pharmaceuticals Completes $25 Million Series B Financing 8/22/2013
Regado Biosciences, Inc. (RGDO) Finally Goes Public, Raised $43 Million 8/22/2013
Orphan Disease Biotech Fate Therapeutics Files for a $69 Million IPO 8/14/2013
Startup Drug-Discovery Company BioMotiv Attracts New Millions and a Key Partner 8/13/2013
GlaxoSmithKline (GSK) Plugs Into Bioelectronics With $50 Million Venture Fund 8/8/2013
Agios Pharmaceuticals Prices Initial Public Offering 7/24/2013
Verastem, Inc. (VSTM) Announces Pricing of Public Offering of Common Stock 7/22/2013
OncoMed Pharmaceuticals, Inc. IPO Rakes in $72 Million 7/18/2013
Intrexon Corporation Files $125 Million IPO 7/10/2013
Cardio3 BioSciences's Recent $29 Million Biotech IPO Relied Heavily on Questionable Research 7/9/2013
PTC Therapeutics, Inc. IPO Raises $125 Million Despite Checkered Past 6/20/2013
Iroko Pharmaceuticals Files for a $145 Million IPO 6/19/2013
bluebird bio Prices Upsized IPO Above the Range at $17 6/19/2013
Onconova Therapeutics Inc. Files for $75 Million IPO 6/18/2013
Epizyme (EPZM) Prices IPO at $15 Per Share, Begins Trading Today 5/31/2013
INSYS Therapeutics Completes $37 Million IPO to Back Medical Marijuana Drug 5/21/2013
Karyopharm Therapeutics Raises $48.2 Million in Series B Financing 5/20/2013
Effector Therapeutics Raises $45 Million Series A to Fight Cancer Tumors 5/20/2013
Esperion Therapeutics, Inc. Files for $70 Million IPO 5/16/2013
Quintiles, Inc. (QTRN)'s $947.4M IPO to Spawn a New Billionaire 5/10/2013
Startup Allecra Therapeutics Raises $19.5 Million Series A Financing 4/18/2013
Portola Pharmaceuticals, Inc. Files for $115 Million IPO 4/15/2013
Biotech Chimerix, Inc. Shines in IPO Debut as Interest Grows in Antiviral Drugs 4/12/2013
Cleave Biosciences Adds $10 Million to Series A Financing 4/9/2013
Biotech Receptos Files for a $86 Million IPO 4/5/2013
Enanta Pharmaceuticals, Inc. Raises $56 Million in IPO 3/21/2013
NABsys, Inc. Raises $20 Million From Investors 3/13/2013
Emergence-Backed Veeva Systems, Inc. Seen Seeking $2 Billion Valuation With IPO 3/12/2013
Omthera Pharmaceuticals, Inc. Files for a $75 Million IPO 3/11/2013
Tesaro, Inc. Nets $91 Million 3/7/2013
Ambit Biosciences Refiles for a $58 Million IPO 2/21/2013
Sophiris Bio Inc. (SHS.TO) Files for a $75 Million IPO 2/19/2013
Third Rock Ventures Launches Jounce Therapeutics With $47 Million 2/15/2013
TetraPhase Pharmaceuticals Files for a $86 Million IPO 2/13/2013
e-Therapeutics plc to Raise $62.7 Million 2/11/2013
IPO Could Value Pfizer Inc. (PFE)'s Zoetis at Up to $12.5 Billion 1/21/2013
Onyx Pharmaceuticals, Inc. (ONXX) Announces Pricing of Public Offering of Common Stock 1/16/2013
InterMune, Inc. (ITMN) Announces Pricing of Concurrent Public Offerings of $105,000,000 Principal Amount of Convertible Senior Notes and 13,500,000 Shares of Common Stock 1/16/2013
Aileron Therapeutics Nabs $12 Million for First-Ever Stapled Peptide Clinical Trial 1/14/2013
Foundation Medicine Expands Series B Financing to $56 Million 1/8/2013
Biotech Startup Transcriptic Receives $1.2 Million in Seed Funding Led by Google Ventures 12/14/2012
Pfizer Inc. (PFE) to Launch Animal-Health Unit IPO in Early 2013 12/14/2012
Sofinnova Ventures Raises $312 Million for Life Sciences 12/11/2012
Fluxion Biosciences Secures $20 Million in Series B Financing 12/4/2012
ArmaGen Technologies, Inc. Announces $17 Million Series A Financing 11/30/2012
Intarcia Therapeutics, Inc. Secures $210 Million Financing to Fund Its Global Phase 3 Program 11/15/2012
Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing 11/14/2012
Pearl Therapeutics Grabs $65 Million in VC Funding, Moves COPD Drug Toward Phase III Trials 11/13/2012
Visterra, Inc. Boosts Series A to $26 Million, Adds Bill & Melinda Gates Foundation as Investor 11/9/2012
Abbott Laboratories (ABT) Announces Pricing of AbbVie's $14.7 Billion Private Placement Notes Offering 11/5/2012
Puma Biotechnology Raises $138 Million in Public Offering of Common Stock 10/26/2012
Aclaris Therapeutics Raises $21 Million in Series A Financing 10/24/2012
Intercept Pharmaceuticals, Kythera Biopharmaceuticals Take Off in IPOs 10/12/2012
KaloBios Pharmaceuticals, Inc. Files for IPO 10/5/2012
Massachusetts Institute of Technology (MIT) Economist Pitches $30 Billion Cancer Megafund 10/2/2012
Google Inc. Venture Fund Eyes Biotech Start-Ups With $1 Billion in Pocket 9/24/2012
Startup Heart Drug Developer MyoKardia Lands $38 Million 9/20/2012
Foundation Medicine, Inc. (FMI) Announces $42.5 Million Series B Financing 9/20/2012
Selexys Pharmaceuticals Corporation Completes $23 Million Equity Financing and Signs Agreement With Novartis Pharmaceuticals Corporation (NVS) for Up to $665 Million 9/19/2012
Intercept Pharmaceuticals Files for $75 Million IPO 9/5/2012
Regulus Therapeutics, Inc. Files for Up to $58 Million IPO 8/20/2012
KV Pharmaceutical Files for Chapter 11; Cites Makena Drug Woes 8/6/2012
Burrill & Company Touts New Life Sciences Fund Worth $505 Million 8/3/2012
Biotech Start-Up Atterocor Raises $16 Million Series A 8/3/2012
Idenix Pharmaceuticals, Inc. (IDIX) Prices Public Offering of Common Stock 8/2/2012
Agile Therapeutics, Inc. Raises $40 Million in a Series C Financing 7/19/2012
Durata Therapeutics, Inc. Prices $68 Million IPO 7/19/2012
Juventas Therapeutics, Inc. Raises $22.2 Million Series B Financing 7/16/2012
Synageva BioPharma (GEVA) Announces $80 Million Proposed Public Offering of Common Stock 7/10/2012
GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug 7/9/2012
Cytokinetics, Inc. (CYTK) Nabs $60 Million Financing 6/20/2012
Tesaro, Inc. Sets Terms for $81 Million US IPO 6/20/2012
Global Blood Therapeutics, Third Rock Ventures’s First West Coast Startup, Gets $41 Million 6/14/2012
New Firm Select BioVentures Seeks $200 Million for Biotech Deals in Sunshine State 6/13/2012
Rhythm Drums Up $25 Million to Advance Diabetes and Obesity Drugs 6/13/2012
Kleiner Perkins Caufield & Byers Launches New $525 Million Venture Fund 5/18/2012
Arena Pharmaceuticals, Inc. (ARNA) Prices Public Offering of Common Stock 5/17/2012
OncoMed Pharmaceuticals, Inc. Files for $115 Million IPO 5/14/2012
Supernus Pharmaceuticals Announces Closing of Initial Public Offering 5/7/2012
Savient Pharmaceuticals, Inc. (SVNT) Plummets as Hedge Fund Claims It's Bankrupt 5/2/2012
Peter Thiel's Breakout Labs Awards Cash to 6 Ambitious Biotech Startups 4/17/2012
Hyperion Therapeutics Files for $58 Million US IPO 4/13/2012
Supernus Pharmaceuticals Sets Terms for $75 Million US IPO 4/12/2012
BioVentures Closes $268 Million Life Sciences Fund 4/10/2012
Merck Teams With Flagship to Bankroll Biotech Start-ups 4/10/2012
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Plot $200 Million Biotech Fund With Index Ventures 3/21/2012
Wellcome Trust to Launch $318 Million Biotech Start-up Fund 3/21/2012
Bellicum Pharmaceuticals, Inc. Closes $20 Million Series B Financing 3/8/2012
Rusnano, US Fund to Invest $760 Million in Pharma Venture 3/6/2012
4s3 Bioscience Lands $20 Million in Venture Funding 3/5/2012
Pfizer Inc. (PFE) Mulls $3 Billion Partial IPO for Animal Healthcare Unit: Report 2/21/2012
ChemoCentryx, Inc. (CCXI) Completes IPO 2/14/2012
Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock 2/13/2012
Celgene (CELG) Pours $15 Million Into Acetylon Pharmaceuticals, Takes "Observer" Role on Board 2/9/2012
Radius Files IPO, Aims for $86 Million 2/7/2012
RaNA Therapeutics, Inc. Emerges With $20.7 Million Startup Financing 1/18/2012
Warp Drive Bio Launches With $125 Million from Third Rock Ventures, Greylock, Sanofi (France) (SAN.PA) 1/10/2012
Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 1/4/2012
Acceleron Pharma Secures $30 Million Private Financing 12/28/2011
Cell Therapeutics, Inc. (CTIC) Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants 12/9/2011
Forbion Capital Raises $50 Million to Invest in Health Companies 12/8/2011
arGEN-X Raises $37 Million in Oversubscribed Series B Round 12/1/2011
Fosun Pharma to Float up to $470 Million in Bonds 11/28/2011
Rib-X Pharmaceuticals, Inc. Files for $80 Million IPO 11/28/2011
Portola Pharmaceuticals, Inc. Announces Completion of $89 Million Financing 11/21/2011
Agios Pharmaceuticals Secures $78 Million Series C Financing 11/17/2011
Clovis Oncology (CLVS) Raises $130 Million in IPO 11/16/2011
NewLink Genetics Raises $43.4 Million in IPO 11/11/2011
Human Genome Sciences, Inc. (HGSI) Prices $430 Million Convertible Notes Offering 11/3/2011
Third Rock Ventures Launches SAGE Therapeutics with $35 Million Backing 10/18/2011
Topica Pharmaceuticals Announces Completion of $27 Million Series B Financing 10/18/2011
Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Third Rock Ventures and Google Inc. Ventures Join as Investors 10/18/2011
Sofinnova Ventures Raises $440 Million for Biotech-Only VC Fund 10/17/2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies 10/12/2011
Kythera Biopharmaceuticals Raises $37.4 Million Financing 9/19/2011
Merck & Co., Inc. (MRK) Creates a $250 Million Venture Capital Fund 9/16/2011
InterMune, Inc. (ITMN) Announces Pricing of Concurrent Public Offerings of 4,000,000 Shares of Common Stock and $135 Million Principal Amount of Convertible Senior Notes 9/14/2011
Valeritas Announces $150 Million Financing 9/13/2011
Orphazyme Raises $19.6 Million in a Series A Financing Round 9/7/2011
VIVUS, Inc. (VVUS) Adds $45.8 Million 8/24/2011
KalVista Pharmaceuticals Launched With $13 Million Series A Funding to Develop Eye Drugs 8/23/2011
Asymchem Laboratories, Inc. Announces $39 Million in VC Funds 8/22/2011
Yaupon Therapeutics Inc. Secures $14.4 Million in Series D Financing 8/11/2011
Enobia Pharma Raises US $40 Million 8/10/2011
SARcode Pulls in $44 Million Series B Financing 7/18/2011
Verastem, Inc. Nabs $32 Million Series B Financing 7/14/2011
DVS Sciences Raises $14.6 Million in Series A Financing to Advance Commercialization of Novel Single-Cell Analysis Technology 7/14/2011
Merrimack Pharmaceuticals Inc. Files $172.5 Million IPO 7/11/2011
Zafgen Secures $33 Million Series C Financing 7/7/2011
Tesaro, Inc. Snags Huge $101 Million Venture Round to Develop Cancer Drugs 6/21/2011
AVEO Oncology (AVEO) Gets $100 Million in Stock Offering 6/16/2011
ReVance Therapeutics, Inc. Announces $45 Million Financing 6/10/2011
Intrexon Corporation Raises $100 Million for Synthetic Biology Initiatives 5/31/2011
Rigel Pharmaceuticals, Inc. (RIGL) Pockets $130 Million in Financing, Seeks To Pick up Pfizer Inc. (PFE)'s Ball and Run With it 5/31/2011
Celldex Therapeutics, Inc. (CLDX) Raises $31.5 Million 5/19/2011
Quintiles, Inc. (QTRN) Seeking $2.23 Billion in Loans for Refinancing 5/11/2011
Naurex Inc. Raises $18 Million to Advance Novel Antidepressant 5/11/2011
Takeda Pharmaceuticals Bets on Fate Therapeutics 5/10/2011
Delenex Therapeutics Extends CHF 30.2 Million Series A Financing Round 5/3/2011